{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:00:10Z","timestamp":1788886810449,"version":"build-2803163510"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T00:00:00Z","timestamp":1698451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T00:00:00Z","timestamp":1698451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University Library of Southern Denmark"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Animal models are widely used to study pathological processes and drug (side) effects in a controlled environment. There is a wide variety\u00a0of methods available for establishing animal models depending on the research question. Commonly used methods in tumor research include xenografting cells (established\/commercially available or primary patient-derived) or whole tumor pieces either orthotopically or heterotopically and the more recent genetically engineered models\u2014each type with their\u00a0own\u00a0advantages and disadvantages. The current systematic review aimed to investigate the meningioma model types used, perform a meta-analysis on tumor take rate\u00a0(TTR), and perform critical appraisal of the included studies. The study also aimed to assess reproducibility, reliability, means of validation and verification of models, alongside pros and cons and uses of the model types.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We searched Medline, Embase, and Web of Science for all in vivo meningioma models. The primary outcome was tumor take rate. Meta-analysis was performed on tumor take rate followed by subgroup analyses on the number of cells and duration of incubation. The validity of the tumor models was assessed qualitatively. We performed critical appraisal of the methodological quality and quality of reporting for all included studies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We included 114 unique records (78 using established cell line models (ECLM), 21\u00a0using primary patient-derived tumor models (PTM), 10 using\u00a0genetically engineered models (GEM), and 11\u00a0using uncategorized\u00a0models). TTRs for ECLM\u00a0were 94% (95% CI 92\u201396)\u00a0for orthotopic and 95% (93\u201396)\u00a0for heterotopic. PTM\u00a0showed lower TTRs\u00a0[orthotopic 53% (33\u201372) and heterotopic 82% (73\u201389)] and finally\u00a0GEM revealed\u00a0a TTR of\u00a034% (26\u201343).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This systematic review shows high consistent TTRs in established cell line models and varying TTRs in primary patient-derived models and genetically engineered models. However, we identified several issues regarding the quality of reporting and the methodological approach that reduce the validity, transparency, and reproducibility of studies and suggest a high risk of publication bias.\u00a0Finally, each tumor model type has specific roles in research\u00a0based on their advantages (and disadvantages).<\/jats:p>\n                <jats:p>Systematic review registration: PROSPERO-ID CRD42022308833.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-04620-7","type":"journal-article","created":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T06:02:29Z","timestamp":1698472949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Meningioma animal models: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4347-6626","authenticated-orcid":false,"given":"Mikkel Schou","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel Seremet","family":"Kofoed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asger Sand","family":"Paludan-M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Bonde","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiit","family":"Mathiesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mawrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wirenfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarne Winther","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte Brinkmann","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Halle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frantz Rom","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,28]]},"reference":[{"issue":"Suppl 5","key":"4620_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","volume":"24","author":"QT Ostrom","year":"2022","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015\u20132019. Neuro Oncol. 2022;24(Suppl 5):v1\u201395.","journal-title":"Neuro Oncol"},{"issue":"3","key":"4620_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/biomedicines6030086","volume":"6","author":"F Nigim","year":"2018","unstructured":"Nigim F, Wakimoto H, Kasper EM, Ackermans L, Temel Y. Emerging medical treatments for meningioma in the molecular era. Biomedicines. 2018;6(3):86.","journal-title":"Biomedicines."},{"issue":"2","key":"4620_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.nec.2015.11.009","volume":"27","author":"WL Bi","year":"2016","unstructured":"Bi WL, Mei Y, Agarwalla PK, Beroukhim R, Dunn IF. Genomic and epigenomic landscape in meningioma. Neurosurg Clin N Am. 2016;27(2):167\u201379.","journal-title":"Neurosurg Clin N Am"},{"issue":"Suppl 1","key":"4620_CR4","doi-asserted-by":"publisher","first-page":"i4","DOI":"10.1093\/neuonc\/noy178","volume":"21","author":"S Suppiah","year":"2019","unstructured":"Suppiah S, Nassiri F, Bi WL, Dunn IF, Hanemann CO, Horbinski CM, et al. Molecular and translational advances in meningiomas. Neuro Oncol. 2019;21(Suppl 1):i4\u201317.","journal-title":"Neuro Oncol"},{"issue":"5","key":"4620_CR5","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","volume":"18","author":"F Sahm","year":"2017","unstructured":"Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S, et al. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol. 2017;18(5):682\u201394.","journal-title":"Lancet Oncol"},{"issue":"5","key":"4620_CR6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41588-022-01061-8","volume":"54","author":"A Choudhury","year":"2022","unstructured":"Choudhury A, Magill ST, Eaton CD, Prager BC, Chen WC, Cady MA, et al. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet. 2022;54(5):649\u201359.","journal-title":"Nat Genet"},{"issue":"5","key":"4620_CR7","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/neuonc\/noab213","volume":"24","author":"J Driver","year":"2022","unstructured":"Driver J, Hoffman SE, Tavakol S, Woodward E, Maury EA, Bhave V, et al. A molecularly integrated grade for meningioma. Neuro Oncol. 2022;24(5):796\u2013808.","journal-title":"Neuro Oncol"},{"issue":"1","key":"4620_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","volume":"20","author":"D Simpson","year":"1957","unstructured":"Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957;20(1):22\u201339.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"4620_CR9","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","volume":"23","author":"R Goldbrunner","year":"2021","unstructured":"Goldbrunner R, Stavrinou P, Jenkinson MD, Sahm F, Mawrin C, Weber DC, et al. EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol. 2021;23(11):1821\u201334.","journal-title":"Neuro Oncol"},{"issue":"1","key":"4620_CR10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/1097-0142(195301)6:1<100::AID-CNCR2820060110>3.0.CO;2-H","volume":"6","author":"ET Krementz","year":"1953","unstructured":"Krementz ET, Greene HS. Heterologous transplantation of human neural tumors. Cancer. 1953;6(1):100\u201310.","journal-title":"Cancer"},{"key":"4620_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3171\/jns.1945.2.4.0315","volume":"2","author":"HS Greene","year":"1945","unstructured":"Greene HS, Arnold H. The homologous and heterologous transplantation of brain and brain tumors. J Neurosurg. 1945;2:315\u201329.","journal-title":"J Neurosurg"},{"issue":"1","key":"4620_CR12","first-page":"36","volume":"12","author":"YS Ishida","year":"1963","unstructured":"Ishida YS, Sato K, Niibe H. Experimental induction of gliogenous tumors in rats. A histopathologic and electron microscope study. Gunma J Med Sci. 1963;12(1):36\u201372.","journal-title":"Gunma J Med Sci"},{"issue":"6","key":"4620_CR13","first-page":"422","volume":"13","author":"HS Greene","year":"1953","unstructured":"Greene HS. The transplantation of human brain tumors to the brains of laboratory animals. Cancer Res. 1953;13(6):422\u20136.","journal-title":"Cancer Res"},{"key":"4620_CR14","first-page":"508","volume":"70","author":"H Miyawaki","year":"1960","unstructured":"Miyawaki H, Ishii S. The heterologous intracerebral transplantation of human brain tumors. Arch Pathol. 1960;70:508\u201319.","journal-title":"Arch Pathol"},{"issue":"2","key":"4620_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF00284007","volume":"86","author":"A Maekawa","year":"1976","unstructured":"Maekawa A, Odashima S, Nakadate M. Induction of tumors in the stomach and nervous system of the ACI\/N rat by continuous oral administration of 1-methyl-3-acetyl-1-nitrosourea. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1976;86(2):195\u2013207.","journal-title":"Z Krebsforsch Klin Onkol Cancer Res Clin Oncol"},{"issue":"3","key":"4620_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000225422","volume":"37","author":"V Ponomarkov","year":"1980","unstructured":"Ponomarkov V, Tomatis L. Long-term testing of vinylidene chloride and chloroprene for carcinogenicity in rats. Oncology. 1980;37(3):136\u201341.","journal-title":"Oncology"},{"issue":"2","key":"4620_CR17","first-page":"341","volume":"27","author":"L Anigstein","year":"1969","unstructured":"Anigstein L, Anigstein DM, Unterharnscheidt FJ. Mouse transplantable tumor induced by human spinal meningioma implant in mice inoculated with human thymus antiserum. Tex Rep Biol Med. 1969;27(2):341\u201366.","journal-title":"Tex Rep Biol Med"},{"issue":"4","key":"4620_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2302\/kjm.24.415","volume":"24","author":"Y Ueyama","year":"1975","unstructured":"Ueyama Y, Ohsawa N, Tamaoki N, Nomura T. Heterotransplantation of human neoplasms in nude mice. Keio J Med. 1975;24(4):415\u201321.","journal-title":"Keio J Med"},{"issue":"4","key":"4620_CR19","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/bjc.1978.95","volume":"37","author":"Y Ueyama","year":"1978","unstructured":"Ueyama Y, Morita K, Ochiai C, Ohsawa N, Hata J, Tamaoki N. Xenotransplantation of a human meningioma and its lung metastasis in nude mice. Br J Cancer. 1978;37(4):644\u20137.","journal-title":"Br J Cancer"},{"issue":"3","key":"4620_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.surneu.2007.06.031","volume":"70","author":"BT Ragel","year":"2008","unstructured":"Ragel BT, Couldwell WT, Gillespie DL, Wendland MM, Whang K, Jensen RL. A comparison of the cell lines used in meningioma research. Surg Neurol. 2008;70(3):295\u2013307.","journal-title":"Surg Neurol"},{"issue":"9","key":"4620_CR21","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/labinvest.3700307","volume":"85","author":"S Puttmann","year":"2005","unstructured":"Puttmann S, Senner V, Braune S, Hillmann B, Exeler R, Rickert CH, et al. Establishment of a benign meningioma cell line by hTERT-mediated immortalization. Lab Invest. 2005;85(9):1163\u201371.","journal-title":"Lab Invest"},{"issue":"3","key":"4620_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1227\/00006123-199009000-00008","volume":"27","author":"WH Lee","year":"1990","unstructured":"Lee WH. Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. Neurosurgery. 1990;27(3):389\u201395.","journal-title":"Neurosurgery"},{"issue":"2","key":"4620_CR23","first-page":"114","volume":"6","author":"IW Mak","year":"2014","unstructured":"Mak IW, Evaniew N, Ghert M. Lost in translation: animal models and clinical trials in cancer treatment. Am J Transl Res. 2014;6(2):114\u20138.","journal-title":"Am J Transl Res"},{"issue":"2","key":"4620_CR24","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3171\/jns.2000.92.2.0306","volume":"92","author":"IE McCutcheon","year":"2000","unstructured":"McCutcheon IE, Friend KE, Gerdes TM, Zhang BM, Wildrick DM, Fuller GN. Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth. J Neurosurg. 2000;92(2):306\u201314.","journal-title":"J Neurosurg"},{"issue":"6","key":"4620_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/cancers12061478","volume":"12","author":"H Zhang","year":"2020","unstructured":"Zhang H, Qi L, Du Y, Huang LF, Braun FK, Kogiso M, et al. Patient-derived orthotopic xenograft (PDOX) mouse models of primary and recurrent meningioma. Cancers (Basel). 2020;12(6):147.","journal-title":"Cancers (Basel)."},{"issue":"1","key":"4620_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneumeth.2011.12.009","volume":"205","author":"S Friedrich","year":"2012","unstructured":"Friedrich S, Schwabe K, Klein R, Krusche CA, Krauss JK, Nakamura M. Comparative morphological and immunohistochemical study of human meningioma after intracranial transplantation into nude mice. J Neurosci Methods. 2012;205(1):1\u20139.","journal-title":"J Neurosci Methods"},{"issue":"9","key":"4620_CR27","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1101\/gad.226302","volume":"16","author":"M Kalamarides","year":"2002","unstructured":"Kalamarides M, Niwa-Kawakita M, Leblois H, Abramowski V, Perricaudet M, Janin A, et al. Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. Genes Dev. 2002;16(9):1060\u20135.","journal-title":"Genes Dev"},{"issue":"1","key":"4620_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1750-3639.2007.00105.x","volume":"18","author":"M Kalamarides","year":"2008","unstructured":"Kalamarides M, Stemmer-Rachamimov AO, Takahashi M, Han ZY, Chareyre F, Niwa-Kawakita M, et al. Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations. Brain Pathol. 2008;18(1):62\u201370.","journal-title":"Brain Pathol"},{"issue":"20","key":"4620_CR29","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1038\/onc.2010.609","volume":"30","author":"M Kalamarides","year":"2011","unstructured":"Kalamarides M, Stemmer-Rachamimov AO, Niwa-Kawakita M, Chareyre F, Taranchon E, Han ZY, et al. Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes. Oncogene. 2011;30(20):2333\u201344.","journal-title":"Oncogene"},{"key":"4620_CR30","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1038\/onc.2012.436","volume":"32","author":"M Peyre","year":"2012","unstructured":"Peyre M, Stemmer-Rachamimov A, Clermont-Taranchon E, Quentin S, El-Taraya N, Walczak C, et al. Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation. Oncogene. 2012;32:4264.","journal-title":"Oncogene"},{"issue":"32","key":"4620_CR31","doi-asserted-by":"publisher","first-page":"32713","DOI":"10.18632\/oncotarget.5296","volume":"6","author":"M Peyre","year":"2015","unstructured":"Peyre M, Salaud C, Clermont-Taranchon E, Niwa-Kawakita M, Goutagny S, Mawrin C, et al. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss. Oncotarget. 2015;6(32):32713\u201322.","journal-title":"Oncotarget"},{"key":"4620_CR32","doi-asserted-by":"publisher","DOI":"10.21037\/cco.2017.05.03","author":"C Mawrin","year":"2017","unstructured":"Mawrin C. Animal models of meningiomas. Chin Clin Oncol. 2017. https:\/\/doi.org\/10.21037\/cco.2017.05.03.","journal-title":"Chin Clin Oncol"},{"issue":"3","key":"4620_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11060-010-0331-5","volume":"99","author":"M Kalamarides","year":"2010","unstructured":"Kalamarides M, Peyre M, Giovannini M. Meningioma mouse models. J Neurooncol. 2010;99(3):325\u201331.","journal-title":"J Neurooncol"},{"issue":"2","key":"4620_CR34","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.yexmp.2015.08.007","volume":"99","author":"PJ Cimino","year":"2015","unstructured":"Cimino PJ. Malignant progression to anaplastic meningioma: neuropathology, molecular pathology, and experimental models. Exp Mol Pathol. 2015;99(2):354\u20139.","journal-title":"Exp Mol Pathol"},{"issue":"15","key":"4620_CR35","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.3390\/cancers13153712","volume":"13","author":"J Boetto","year":"2021","unstructured":"Boetto J, Peyre M, Kalamarides M. Mouse models in meningioma research: a systematic review. Cancers (Basel). 2021;13(15):3712.","journal-title":"Cancers (Basel)."},{"key":"4620_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.","journal-title":"BMJ"},{"key":"4620_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Measur. 1960;20:37\u201346.","journal-title":"Educ Psychol Measur"},{"key":"4620_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"J Higgins","year":"2019","unstructured":"Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane handbook for systematic reviews of interventions. 2nd ed. Chichester: Wiley; 2019.","edition":"2"},{"key":"4620_CR39","unstructured":"Andersen MS, Kofoed MS, Paludan-M\u00fcller AS, Pedersen CB, Mathiesen T, Mawrin C, et al. A unifying tool for critical appraisal of methodological quality, quality of reporting and risk of bias in animal research. Submitted to BMC Medical Research Methodology. 2023"},{"issue":"5","key":"4620_CR40","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1161\/01.STR.0000125719.25853.20","volume":"35","author":"MR Macleod","year":"2004","unstructured":"Macleod MR, O\u2019Collins T, Howells DW, Donnan GA. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke. 2004;35(5):1203\u20138.","journal-title":"Stroke"},{"issue":"7","key":"4620_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, et al. Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 2020;18(7): e3000411.","journal-title":"PLoS Biol"},{"key":"4620_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"4620_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.canlet.2011.08.022","volume":"313","author":"VR Gogineni","year":"2011","unstructured":"Gogineni VR, Nalla AK, Gupta R, Dinh DH, Klopfenstein JD, Rao JS. Chk2-mediated G2\/M cell cycle arrest maintains radiation resistance in malignant meningioma cells. Cancer Lett. 2011;313(1):64\u201375.","journal-title":"Cancer Lett"},{"issue":"7","key":"4620_CR44","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s12094-019-02240-6","volume":"22","author":"A Das","year":"2020","unstructured":"Das A, Alshareef M, Henderson F Jr, Martinez Santos JL, Vandergrift WA 3rd, Lindhorst SM, et al. Ganoderic acid A\/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth. Clin Transl Oncol. 2020;22(7):1138\u201345.","journal-title":"Clin Transl Oncol"},{"issue":"12","key":"4620_CR45","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1093\/neuonc\/noab114","volume":"23","author":"Z Bao","year":"2021","unstructured":"Bao Z, Hua L, Ye Y, Wang D, Li C, Xie Q, et al. MEF2C silencing downregulates NF2 and E-cadherin and enhances erastin-induced ferroptosis in meningioma. Neuro Oncol. 2021;23(12):2014\u201327.","journal-title":"Neuro Oncol"},{"issue":"2","key":"4620_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/nan.12571","volume":"46","author":"H Kim","year":"2020","unstructured":"Kim H, Park KJ, Ryu BK, Park DH, Kong DS, Chong K, et al. Forkhead box M1 (FOXM1) transcription factor is a key oncogenic driver of aggressive human meningioma progression. Neuropathol Appl Neurobiol. 2020;46(2):125\u201341.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"4620_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40478-020-00912-x","volume":"8","author":"N von Spreckelsen","year":"2020","unstructured":"von Spreckelsen N, Waldt N, Poetschke R, Kesseler C, Dohmen H, Jiao HK, et al. KLF4(K409Q)-mutated meningiomas show enhanced hypoxia signaling and respond to mTORC1 inhibitor treatment. Acta Neuropathol Commun. 2020;8(1):41.","journal-title":"Acta Neuropathol Commun"},{"key":"4620_CR48","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.omto.2020.11.004","volume":"20","author":"L Guo","year":"2021","unstructured":"Guo L, Cui J, Wang H, Medina R, Zhang S, Zhang X, et al. Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways. Mol Ther Oncolytics. 2021;20:119\u201331.","journal-title":"Mol Ther Oncolytics"},{"issue":"20","key":"4620_CR49","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.130688","volume":"4","author":"AJ Giles","year":"2019","unstructured":"Giles AJ, Hao S, Padget M, Song H, Zhang W, Lynes J, et al. Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK. JCI Insight. 2019;4(20): e130688.","journal-title":"JCI Insight."},{"key":"4620_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.canlet.2017.11.035","volume":"415","author":"WS Ho","year":"2018","unstructured":"Ho WS, Sizdahkhani S, Hao S, Song H, Seldomridge A, Tandle A, et al. LB-100, a novel protein phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation. Cancer Lett. 2018;415:217\u201326.","journal-title":"Cancer Lett"},{"issue":"5","key":"4620_CR51","first-page":"580","volume":"48","author":"S Wang","year":"2018","unstructured":"Wang S, Liu X, Wang W, Tu Y, Wang C, Mei J, et al. The effects of silencing the Her2 gene on proliferation and angiogenesis of meningioma cells in vivo and in vitro. Ann Clin Lab Sci. 2018;48(5):580\u20136.","journal-title":"Ann Clin Lab Sci"},{"key":"4620_CR52","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3389\/fonc.2020.01441","volume":"10","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Song LR, Huo XL, Wang L, Zhang GB, Hao SY, et al. MicroRNA-221\/222 inhibits the radiation-induced invasiveness and promotes the radiosensitivity of malignant meningioma cells. Front Oncol. 2020;10:1441.","journal-title":"Front Oncol"},{"key":"4620_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejca.2016.12.004","volume":"73","author":"M Tuchen","year":"2017","unstructured":"Tuchen M, Wilisch-Neumann A, Daniel EA, Baldauf L, Pachow D, Scholz J, et al. Receptor tyrosine kinase inhibition by regorafenib\/sorafenib inhibits growth and invasion of meningioma cells. Eur J Cancer. 2017;73:9\u201321.","journal-title":"Eur J Cancer"},{"issue":"5","key":"4620_CR54","first-page":"5443","volume":"14","author":"O Bahr","year":"2017","unstructured":"Bahr O, Gross S, Harter PN, Kirches E, Mawrin C, Steinbach JP, et al. ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors. Oncol Lett. 2017;14(5):5443\u201351.","journal-title":"Oncol Lett"},{"issue":"11","key":"4620_CR55","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s12094-020-02341-7","volume":"22","author":"A Das","year":"2020","unstructured":"Das A, Alshareef M, Martinez Santos JL, Porto GBF, McDonald DG, Infinger LK, et al. Evaluating anti-tumor activity of palbociclib plus radiation in anaplastic and radiation-induced meningiomas: pre-clinical investigations. Clin Transl Oncol. 2020;22(11):2017\u201325.","journal-title":"Clin Transl Oncol"},{"issue":"2","key":"4620_CR56","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3892\/or.2016.4849","volume":"36","author":"Z Wang","year":"2016","unstructured":"Wang Z, Wang W, Xu S, Wang S, Tu Y, Xiong Y, et al. The role of MAPK signaling pathway in the Her-2-positive meningiomas. Oncol Rep. 2016;36(2):685\u201395.","journal-title":"Oncol Rep"},{"issue":"1","key":"4620_CR57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11060-014-1603-2","volume":"121","author":"KJ Park","year":"2015","unstructured":"Park KJ, Yu MO, Song NH, Kong DS, Park DH, Chae YS, et al. Expression of astrocyte elevated gene-1 (AEG-1) in human meningiomas and its roles in cell proliferation and survival. J Neurooncol. 2015;121(1):31\u20139.","journal-title":"J Neurooncol"},{"issue":"2","key":"4620_CR58","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10014-014-0190-4","volume":"32","author":"K Iwami","year":"2015","unstructured":"Iwami K, Momota H, Fujii M, Natsume A, Yagi S, Toriyama K, et al. Anaplastic meningioma with rapid growth after omental flap transposition: a case report and experimental study. Brain Tumor Pathol. 2015;32(2):137\u201344.","journal-title":"Brain Tumor Pathol"},{"issue":"19","key":"4620_CR59","doi-asserted-by":"publisher","first-page":"5402","DOI":"10.1158\/1078-0432.CCR-12-0299","volume":"19","author":"A Wilisch-Neumann","year":"2013","unstructured":"Wilisch-Neumann A, Kliese N, Pachow D, Schneider T, Warnke JP, Braunsdorf WE, et al. The integrin inhibitor cilengitide affects meningioma cell motility and invasion. Clin Cancer Res. 2013;19(19):5402\u201312.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"4620_CR60","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/neuonc\/not007","volume":"15","author":"K Iwami","year":"2013","unstructured":"Iwami K, Natsume A, Ohno M, Ikeda H, Mineno J, Nukaya I, et al. Adoptive transfer of genetically modified Wilms\u2019 tumor 1-specific T cells in a novel malignant skull base meningioma model. Neuro Oncol. 2013;15(6):747\u201358.","journal-title":"Neuro Oncol"},{"issue":"5","key":"4620_CR61","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/1078-0432.CCR-12-1904","volume":"19","author":"D Pachow","year":"2013","unstructured":"Pachow D, Andrae N, Kliese N, Angenstein F, Stork O, Wilisch-Neumann A, et al. mTORC1 inhibitors suppress meningioma growth in mouse models. Clin Cancer Res. 2013;19(5):1180\u20139.","journal-title":"Clin Cancer Res"},{"issue":"39","key":"4620_CR62","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1038\/onc.2012.468","volume":"32","author":"N Kliese","year":"2013","unstructured":"Kliese N, Gobrecht P, Pachow D, Andrae N, Wilisch-Neumann A, Kirches E, et al. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells. Oncogene. 2013;32(39):4712\u201320.","journal-title":"Oncogene"},{"issue":"8","key":"4620_CR63","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/neuonc\/noq004","volume":"12","author":"D Haase","year":"2010","unstructured":"Haase D, Schmidl S, Ewald C, Kalff R, Huebner C, Firsching R, et al. Fatty acid synthase as a novel target for meningioma therapy. Neuro Oncol. 2010;12(8):844\u201354.","journal-title":"Neuro Oncol"},{"key":"4620_CR64","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12935-016-0361-y","volume":"16","author":"Y Ge","year":"2016","unstructured":"Ge Y, Xu K. Alpha-synuclein contributes to malignant progression of human meningioma via the Akt\/mTOR pathway. Cancer Cell Int. 2016;16:86.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"4620_CR65","first-page":"937","volume":"33","author":"O Kargiotis","year":"2008","unstructured":"Kargiotis O, Chetty C, Gogineni V, Gondi CS, Pulukuri SM, Kyritsis AP, et al. uPA\/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo. Int J Oncol. 2008;33(5):937\u201347.","journal-title":"Int J Oncol"},{"issue":"2","key":"4620_CR66","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1750-3639.2007.00109.x","volume":"18","author":"GS Baia","year":"2008","unstructured":"Baia GS, Dinca EB, Ozawa T, Kimura ET, McDermott MW, James CD, et al. An orthotopic skull base model of malignant meningioma. Brain Pathol. 2008;18(2):172\u20139.","journal-title":"Brain Pathol"},{"issue":"2","key":"4620_CR67","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3171\/JNS\/2008\/108\/2\/0304","volume":"108","author":"BT Ragel","year":"2008","unstructured":"Ragel BT, Elam IL, Gillespie DL, Flynn JR, Kelly DA, Mabey D, et al. A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. Lab Investig J Neurosurg. 2008;108(2):304\u201310.","journal-title":"Lab Investig J Neurosurg"},{"issue":"1","key":"4620_CR68","first-page":"5","volume":"31","author":"P Tummalapalli","year":"2007","unstructured":"Tummalapalli P, Gondi CS, Dinh DH, Gujrati M, Rao JS. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis. Int J Oncol. 2007;31(1):5\u201317.","journal-title":"Int J Oncol"},{"issue":"4","key":"4620_CR69","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1227\/01.NEU.0000255397.00410.8F","volume":"60","author":"TG Cargioli","year":"2007","unstructured":"Cargioli TG, Ugur HC, Ramakrishna N, Chan J, Black PM, Carroll RS. Establishment of an in vivo meningioma model with human telomerase reverse transcriptase. Neurosurgery. 2007;60(4):750\u20139 (discussion 9\u201360).","journal-title":"Neurosurgery"},{"issue":"5","key":"4620_CR70","first-page":"1039","volume":"31","author":"P Tummalapalli","year":"2007","unstructured":"Tummalapalli P, Spomar D, Gondi CS, Olivero WC, Gujrati M, Dinh DH, et al. RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis. Int J Oncol. 2007;31(5):1039\u201350.","journal-title":"Int J Oncol"},{"issue":"3","key":"4620_CR71","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3171\/jns.2007.106.3.455","volume":"106","author":"V Gupta","year":"2007","unstructured":"Gupta V, Su YS, Samuelson CG, Liebes LF, Chamberlain MC, Hofman FM, et al. Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas. J Neurosurg. 2007;106(3):455\u201362.","journal-title":"J Neurosurg"},{"issue":"3","key":"4620_CR72","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/cncr.22441","volume":"109","author":"BT Ragel","year":"2007","unstructured":"Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT. Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. Cancer. 2007;109(3):588\u201397.","journal-title":"Cancer"},{"issue":"5","key":"4620_CR73","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1227\/01.NEU.0000245597.46581.FB","volume":"59","author":"BT Ragel","year":"2006","unstructured":"Ragel BT, Gillespie DL, Kushnir V, Polevaya N, Kelly D, Jensen RL. Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro. Neurosurgery. 2006;59(5):1109\u201320 (discussion 20-1).","journal-title":"Neurosurgery"},{"issue":"1","key":"4620_CR74","first-page":"25","volume":"29","author":"S Kondraganti","year":"2006","unstructured":"Kondraganti S, Gondi CS, Gujrati M, McCutcheon I, Dinh DH, Rao JS, et al. Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line. Int J Oncol. 2006;29(1):25\u201332.","journal-title":"Int J Oncol"},{"issue":"6","key":"4620_CR75","first-page":"1353","volume":"28","author":"S Kondraganti","year":"2006","unstructured":"Kondraganti S, Gondi CS, McCutcheon I, Dinh DH, Gujrati M, Rao JS, et al. RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth. Int J Oncol. 2006;28(6):1353\u201360.","journal-title":"Int J Oncol"},{"issue":"2","key":"4620_CR76","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/ana.20201","volume":"56","author":"EI Surace","year":"2004","unstructured":"Surace EI, Lusis E, Haipek CA, Gutmann DH. Functional significance of S6K overexpression in meningioma progression. Ann Neurol. 2004;56(2):295\u20138.","journal-title":"Ann Neurol"},{"issue":"4","key":"4620_CR77","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/sj.neo.7900243","volume":"4","author":"B Salhia","year":"2002","unstructured":"Salhia B, Rutka JT, Lingwood C, Nutikka A, Van Furth WR. The treatment of malignant meningioma with verotoxin. Neoplasia. 2002;4(4):304\u201311.","journal-title":"Neoplasia"},{"issue":"4","key":"4620_CR78","first-page":"809","volume":"36","author":"V Rao Gogineni","year":"2010","unstructured":"Rao Gogineni V, Kumar Nalla A, Gupta R, Gorantla B, Gujrati M, Dinh DH, et al. Radiation-inducible silencing of uPA and uPAR in vitro and in vivo in meningioma. Int J Oncol. 2010;36(4):809\u201316.","journal-title":"Int J Oncol"},{"key":"4620_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2021.109141","volume":"356","author":"N Waldt","year":"2021","unstructured":"Waldt N, Kesseler C, Fala P, John P, Kirches E, Angenstein F, et al. Crispr\/Cas-based modeling of NF2 loss in meningioma cells. J Neurosci Methods. 2021;356: 109141.","journal-title":"J Neurosci Methods"},{"issue":"12","key":"4620_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.170","volume":"3","author":"VR Gogineni","year":"2012","unstructured":"Gogineni VR, Gupta R, Nalla AK, Velpula KK, Rao JS. uPAR and cathepsin B shRNA impedes TGF-beta1-driven proliferation and invasion of meningioma cells in a XIAP-dependent pathway. Cell Death Dis. 2012;3(12): e439.","journal-title":"Cell Death Dis"},{"issue":"4","key":"4620_CR81","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1017\/S0317167100003036","volume":"30","author":"WR van Furth","year":"2003","unstructured":"van Furth WR, Laughlin S, Taylor MD, Salhia B, Mainprize T, Henkelman M, et al. Imaging of murine brain tumors using a 1.5 Tesla clinical MRI system. Can J Neurol Sci. 2003;30(4):326\u201332.","journal-title":"Can J Neurol Sci"},{"issue":"8","key":"4620_CR82","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cellsig.2011.03.011","volume":"23","author":"AK Nalla","year":"2011","unstructured":"Nalla AK, Gogineni VR, Gupta R, Dinh DH, Rao JS. Suppression of uPA and uPAR blocks radiation-induced MCP-1 mediated recruitment of endothelial cells in meningioma. Cell Signal. 2011;23(8):1299\u2013310.","journal-title":"Cell Signal"},{"issue":"2","key":"4620_CR83","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12780","volume":"48","author":"P John","year":"2022","unstructured":"John P, Waldt N, Liebich J, Kesseler C, Schnabel S, Angenstein F, et al. AKT1(E17K) -mutated meningioma cell lines respond to treatment with the AKT inhibitor AZD5363. Neuropathol Appl Neurobiol. 2022;48(2): e12780.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"4620_CR84","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/cas.15221","volume":"113","author":"T Nakano","year":"2022","unstructured":"Nakano T, Fujimoto K, Tomiyama A, Takahashi M, Achiha T, Arita H, et al. Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma. Cancer Sci. 2022;113(2):697\u2013708.","journal-title":"Cancer Sci"},{"issue":"1","key":"4620_CR85","first-page":"vdab085","volume":"3","author":"C Horbinski","year":"2021","unstructured":"Horbinski C, Xi G, Wang Y, Hashizume R, Gopalakrishnan M, Phillips JJ, et al. The effects of palbociclib in combination with radiation in preclinical models of aggressive meningioma. Neurooncol Adv. 2021;3(1):vdab085.","journal-title":"Neurooncol Adv."},{"key":"4620_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.836257","volume":"12","author":"Y Deng","year":"2022","unstructured":"Deng Y, Hu B, Miao Y, Wang J, Zhang S, Wan H, et al. A nicotinamide phosphoribosyltransferase inhibitor, FK866, suppresses the growth of anaplastic meningiomas and inhibits immune checkpoint expression by regulating STAT1. Front Oncol. 2022;12: 836257.","journal-title":"Front Oncol"},{"key":"4620_CR87","first-page":"5574555","volume":"2021","author":"X Chen","year":"2021","unstructured":"Chen X, Tian F, Lun P, Feng Y. Curcumin inhibits HGF-induced EMT by regulating c-MET-dependent PI3K\/Akt\/mTOR signaling pathways in meningioma. Evid Based Complement Alternat Med. 2021;2021:5574555.","journal-title":"Evid Based Complement Alternat Med"},{"key":"4620_CR88","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1016\/j.wneu.2021.04.005","volume":"151","author":"A Yang","year":"2021","unstructured":"Yang A, Yang X, Wang J, Wang X, Wu H, Fan L, et al. Effects of the tight junction protein CLDN6 on cell migration and invasion in high-grade meningioma. World Neurosurg. 2021;151:e208\u201316.","journal-title":"World Neurosurg"},{"issue":"9","key":"4620_CR89","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/neuonc\/noy046","volume":"20","author":"SP Angus","year":"2018","unstructured":"Angus SP, Oblinger JL, Stuhlmiller TJ, DeSouza PA, Beauchamp RL, Witt L, et al. EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma. Neuro Oncol. 2018;20(9):1185\u201396.","journal-title":"Neuro Oncol"},{"issue":"4","key":"4620_CR90","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.18632\/oncotarget.2810","volume":"6","author":"HY Chow","year":"2015","unstructured":"Chow HY, Dong B, Duron SG, Campbell DA, Ong CC, Hoeflich KP, et al. Group I Paks as therapeutic targets in NF2-deficient meningioma. Oncotarget. 2015;6(4):1981\u201394.","journal-title":"Oncotarget"},{"issue":"2","key":"4620_CR91","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1158\/0008-5472.CAN-12-1888","volume":"73","author":"SS Burns","year":"2013","unstructured":"Burns SS, Akhmametyeva EM, Oblinger JL, Bush ML, Huang J, Senner V, et al. Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth. Cancer Res. 2013;73(2):792\u2013803.","journal-title":"Cancer Res"},{"issue":"7","key":"4620_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252048","volume":"16","author":"LS Chang","year":"2021","unstructured":"Chang LS, Oblinger JL, Smith AE, Ferrer M, Angus SP, Hawley E, et al. Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK. PLoS ONE. 2021;16(7): e0252048.","journal-title":"PLoS ONE"},{"issue":"5","key":"4620_CR93","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/ph14050427","volume":"14","author":"K Chen","year":"2021","unstructured":"Chen K, Si Y, Ou J, Guan JS, Kim S, Ernst P, et al. Antibody-drug conjugate to treat meningiomas. Pharmaceuticals (Basel). 2021;14(5):427.","journal-title":"Pharmaceuticals (Basel)"},{"key":"4620_CR94","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.wneu.2015.09.060","volume":"86","author":"M Karsy","year":"2016","unstructured":"Karsy M, Hoang N, Barth T, Burt L, Dunson W, Gillespie DL, et al. Combined hydroxyurea and verapamil in the clinical treatment of refractory meningioma: human and orthotopic xenograft studies. World Neurosurg. 2016;86:210\u20139.","journal-title":"World Neurosurg"},{"issue":"11","key":"4620_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111624","volume":"9","author":"ML Soto-Montenegro","year":"2014","unstructured":"Soto-Montenegro ML, Pena-Zalbidea S, Mateos-Perez JM, Oteo M, Romero E, Morcillo MA, et al. Meningiomas: a comparative study of 68Ga-DOTATOC, 68Ga-DOTANOC and 68Ga-DOTATATE for molecular imaging in mice. PLoS ONE. 2014;9(11): e111624.","journal-title":"PLoS ONE"},{"issue":"4","key":"4620_CR96","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s11307-018-1161-7","volume":"20","author":"J Cal-Gonzalez","year":"2018","unstructured":"Cal-Gonzalez J, Vaquero JJ, Herraiz JL, Perez-Liva M, Soto-Montenegro ML, Pena-Zalbidea S, et al. Improving PET quantification of small animal [(68)Ga]DOTA-labeled PET\/CT studies by using a CT-based positron range correction. Mol Imaging Biol. 2018;20(4):584\u201393.","journal-title":"Mol Imaging Biol"},{"issue":"2","key":"4620_CR97","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11060-021-03739-1","volume":"153","author":"BM Dijkstra","year":"2021","unstructured":"Dijkstra BM, de Jong M, Stroet MCM, Andreae F, Dulfer SE, Everts M, et al. Evaluation of Ac-Lys(0)(IRDye800CW)Tyr(3)-octreotate as a novel tracer for SSTR(2)-targeted molecular fluorescence guided surgery in meningioma. J Neurooncol. 2021;153(2):211\u201322.","journal-title":"J Neurooncol"},{"issue":"1","key":"4620_CR98","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ame2.12050","volume":"2","author":"F La Cava","year":"2019","unstructured":"La Cava F, Fringuello Mingo A, Irrera P, Di Vito A, Cordaro A, Brioschi C, et al. Orthotopic induction of CH157MN convexity and skull base meningiomas into nude mice using stereotactic surgery and MRI characterization. Anim Model Exp Med. 2019;2(1):58\u201363.","journal-title":"Anim Model Exp Med"},{"issue":"4","key":"4620_CR99","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1750-3639.2010.00464.x","volume":"21","author":"A Petermann","year":"2011","unstructured":"Petermann A, Haase D, Wetzel A, Balavenkatraman KK, Tenev T, Guhrs KH, et al. Loss of the protein-tyrosine phosphatase DEP-1\/PTPRJ drives meningioma cell motility. Brain Pathol. 2011;21(4):405\u201318.","journal-title":"Brain Pathol"},{"issue":"11","key":"4620_CR100","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1002\/1097-0142(19891201)64:11<2243::AID-CNCR2820641110>3.0.CO;2-S","volume":"64","author":"K Tanaka","year":"1989","unstructured":"Tanaka K, Sato C, Maeda Y, Koike M, Matsutani M, Yamada K, et al. Establishment of a human malignant meningioma cell line with amplified c-myc oncogene. Cancer. 1989;64(11):2243\u20139.","journal-title":"Cancer"},{"issue":"3","key":"4620_CR101","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11060-018-03009-7","volume":"140","author":"CG Skibinski","year":"2018","unstructured":"Skibinski CG, Williamson T, Riggins GJ. Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma. J Neurooncol. 2018;140(3):529\u201338.","journal-title":"J Neurooncol"},{"issue":"53","key":"4620_CR102","doi-asserted-by":"publisher","first-page":"90996","DOI":"10.18632\/oncotarget.18827","volume":"8","author":"H Takeda","year":"2017","unstructured":"Takeda H, Okada M, Kuramoto K, Suzuki S, Sakaki H, Sanomachi T, et al. Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo. Oncotarget. 2017;8(53):90996\u20131008.","journal-title":"Oncotarget"},{"issue":"7","key":"4620_CR103","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/neuonc\/not028","volume":"15","author":"H Kanno","year":"2013","unstructured":"Kanno H, Nishihara H, Wang L, Yuzawa S, Kobayashi H, Tsuda M, et al. Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma. Neuro Oncol. 2013;15(7):853\u201364.","journal-title":"Neuro Oncol"},{"issue":"4","key":"4620_CR104","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1749-0774.2004.tb00045.x","volume":"17","author":"I Ishiwata","year":"2004","unstructured":"Ishiwata I, Ishiwata C, Ishiwata E, Sato Y, Kiguchi K, Tachibana T, et al. In vitro culture of various typed meningiomas and characterization of a human malignant meningioma cell line (HKBMM). Hum Cell. 2004;17(4):211\u20137.","journal-title":"Hum Cell"},{"key":"4620_CR105","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12967-015-0596-8","volume":"13","author":"SK Michelhaugh","year":"2015","unstructured":"Michelhaugh SK, Guastella AR, Varadarajan K, Klinger NV, Parajuli P, Ahmad A, et al. Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1. J Transl Med. 2015;13:227.","journal-title":"J Transl Med"},{"issue":"1","key":"4620_CR106","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF01058456","volume":"23","author":"T Yazaki","year":"1995","unstructured":"Yazaki T, Takamiya Y, Costello PC, Mineta T, Menon AG, Rabkin SD, et al. Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470. J Neurooncol. 1995;23(1):23\u20139.","journal-title":"J Neurooncol"},{"issue":"2","key":"4620_CR107","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1111\/nan.12166","volume":"41","author":"S Jalali","year":"2015","unstructured":"Jalali S, Singh S, Agnihotri S, Wataya T, Salehi F, Alkins R, et al. A role for matrix remodelling proteins in invasive and malignant meningiomas. Neuropathol Appl Neurobiol. 2015;41(2):e16-28.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"4620_CR108","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1021\/pr900834h","volume":"9","author":"O Saydam","year":"2010","unstructured":"Saydam O, Senol O, Schaaij-Visser TB, Pham TV, Piersma SR, Stemmer-Rachamimov AO, et al. Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas. J Proteome Res. 2010;9(1):485\u201394.","journal-title":"J Proteome Res"},{"issue":"14","key":"4620_CR109","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1038\/onc.2014.120","volume":"34","author":"O Senol","year":"2015","unstructured":"Senol O, Schaaij-Visser TB, Erkan EP, Dorfer C, Lewandrowski G, Pham TV, et al. miR-200a-mediated suppression of non-muscle heavy chain IIb inhibits meningioma cell migration and tumor growth in vivo. Oncogene. 2015;34(14):1790\u20138.","journal-title":"Oncogene"},{"issue":"4","key":"4620_CR110","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/cancers11040545","volume":"11","author":"G Jungwirth","year":"2019","unstructured":"Jungwirth G, Yu T, Moustafa M, Rapp C, Warta R, Jungk C, et al. Identification of KIF11 as a novel target in meningioma. Cancers (Basel). 2019;11(4):545.","journal-title":"Cancers (Basel)."},{"key":"4620_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.02.016","volume":"506","author":"G Jungwirth","year":"2021","unstructured":"Jungwirth G, Yu T, Cao J, Eddine MA, Moustafa M, Warta R, et al. KIF11 inhibitors filanesib and ispinesib inhibit meningioma growth in vitro and in vivo. Cancer Lett. 2021;506:1\u201310.","journal-title":"Cancer Lett"},{"issue":"6","key":"4620_CR112","doi-asserted-by":"publisher","first-page":"388","DOI":"10.14348\/molcells.2022.2232","volume":"45","author":"Y Ding","year":"2022","unstructured":"Ding Y, Ge Y, Wang D, Liu Q, Sun S, Hua L, et al. LncRNA-IMAT1 promotes invasion of meningiomas by suppressing KLF4\/hsa-miR22-3p\/Snai1 pathway. Mol Cells. 2022;45(6):388\u2013402.","journal-title":"Mol Cells"},{"issue":"9","key":"4620_CR113","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1093\/neuonc\/now031","volume":"18","author":"F Nigim","year":"2016","unstructured":"Nigim F, Esaki S, Hood M, Lelic N, James MF, Ramesh V, et al. A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus. Neuro Oncol. 2016;18(9):1278\u201387.","journal-title":"Neuro Oncol"},{"issue":"4","key":"4620_CR114","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11523-019-00654-4","volume":"14","author":"F Nigim","year":"2019","unstructured":"Nigim F, Kiyokawa J, Gurtner A, Kawamura Y, Hua L, Kasper EM, et al. A monoclonal antibody against beta1 integrin inhibits proliferation and increases survival in an orthotopic model of high-grade meningioma. Target Oncol. 2019;14(4):479\u201389.","journal-title":"Target Oncol"},{"issue":"23","key":"4620_CR115","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.3390\/cancers13235898","volume":"13","author":"T Yu","year":"2021","unstructured":"Yu T, Cao J, Alaa Eddine M, Moustafa M, Mock A, Erkut C, et al. Receptor-tyrosine kinase inhibitor ponatinib inhibits meningioma growth in vitro and in vivo. Cancers (Basel). 2021;13(23):5898.","journal-title":"Cancers (Basel)."},{"key":"4620_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.aanat.2021.151752","volume":"237","author":"S Linsler","year":"2021","unstructured":"Linsler S, Muller SJ, Muller A, Senger S, Oertel JM. Fluorescence image-guided resection of intracranial meningioma: an experimental in vivo study on nude mice. Ann Anat. 2021;237: 151752.","journal-title":"Ann Anat"},{"issue":"1","key":"4620_CR117","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s12035-016-9763-z","volume":"54","author":"C Jiang","year":"2017","unstructured":"Jiang C, Song T, Li J, Ao F, Gong X, Lu Y, et al. RAS promotes proliferation and resistances to apoptosis in meningioma. Mol Neurobiol. 2017;54(1):779\u201387.","journal-title":"Mol Neurobiol"},{"key":"4620_CR118","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.biomaterials.2015.03.058","volume":"56","author":"MH Ding","year":"2015","unstructured":"Ding MH, Wang Z, Jiang L, Fu HL, Gao J, Lin XB, et al. The transducible TAT-RIZ1-PR protein exerts histone methyltransferase activity and tumor-suppressive functions in human malignant meningiomas. Biomaterials. 2015;56:165\u201378.","journal-title":"Biomaterials"},{"issue":"1","key":"4620_CR119","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00701-012-1534-7","volume":"155","author":"S Friedrich","year":"2013","unstructured":"Friedrich S, Schwabe K, Grote M, Krauss JK, Nakamura M. Effect of systemic celecoxib on human meningioma after intracranial transplantation into nude mice. Acta Neurochir (Wien). 2013;155(1):173\u201382.","journal-title":"Acta Neurochir (Wien)"},{"issue":"1","key":"4620_CR120","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11596-007-0125-y","volume":"27","author":"J Chen","year":"2007","unstructured":"Chen J, Zhang H, Wang H. Experimental study on the inhibitory effects of verapamil on the proliferation of meningiomas cells. J Huazhong Univ Sci Technol Med Sci. 2007;27(1):88\u201390.","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"issue":"3","key":"4620_CR121","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s11060-011-0705-3","volume":"106","author":"D Hu","year":"2012","unstructured":"Hu D, Wang X, Mao Y, Zhou L. Identification of CD105 (endoglin)-positive stem-like cells in rhabdoid meningioma. J Neurooncol. 2012;106(3):505\u201317.","journal-title":"J Neurooncol"},{"issue":"4","key":"4620_CR122","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/02688690120072487","volume":"15","author":"GM Malham","year":"2001","unstructured":"Malham GM, Thomsen RJ, Synek BJ, Baguley BC. Establishment of primary human meningiomas as subcutaneous xenografts in mice. Br J Neurosurg. 2001;15(4):328\u201334.","journal-title":"Br J Neurosurg"},{"issue":"5","key":"4620_CR123","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0090-3019(01)00444-X","volume":"55","author":"RL Jensen","year":"2001","unstructured":"Jensen RL, Wurster RD. Calcium channel antagonists inhibit growth of subcutaneous xenograft meningiomas in nude mice. Surg Neurol. 2001;55(5):275\u201383.","journal-title":"Surg Neurol"},{"issue":"3","key":"4620_CR124","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3171\/jns.2001.94.3.0487","volume":"94","author":"IE McCutcheon","year":"2001","unstructured":"McCutcheon IE, Flyvbjerg A, Hill H, Li J, Bennett WF, Scarlett JA, et al. Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice. J Neurosurg. 2001;94(3):487\u201392.","journal-title":"J Neurosurg"},{"issue":"5","key":"4620_CR125","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3171\/jns.1997.86.5.0845","volume":"86","author":"UM Schrell","year":"1997","unstructured":"Schrell UM, Rittig MG, Anders M, Kiesewetter F, Marschalek R, Koch UH, et al. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway. J Neurosurg. 1997;86(5):845\u201352.","journal-title":"J Neurosurg"},{"issue":"3","key":"4620_CR126","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3171\/jns.1994.80.3.0527","volume":"80","author":"Y Matsuda","year":"1994","unstructured":"Matsuda Y, Kawamoto K, Kiya K, Kurisu K, Sugiyama K, Uozumi T. Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo. J Neurosurg. 1994;80(3):527\u201334.","journal-title":"J Neurosurg"},{"issue":"4","key":"4620_CR127","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3171\/jns.1989.71.4.0545","volume":"71","author":"A Medhkour","year":"1989","unstructured":"Medhkour A, Van Roey M, Sobel RA, Fingert HJ, Lee J, Martuza RL. Implantation of human meningiomas into the subrenal capsule of the nude mouse. A model for studies of tumor growth. J Neurosurg. 1989;71(4):545\u201350.","journal-title":"J Neurosurg"},{"issue":"4","key":"4620_CR128","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3171\/jns.1987.66.4.0584","volume":"66","author":"JJ Olson","year":"1987","unstructured":"Olson JJ, Beck DW, Schlechte JA, Loh PM. Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice. J Neurosurg. 1987;66(4):584\u20137.","journal-title":"J Neurosurg"},{"issue":"4","key":"4620_CR129","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3171\/jns.1992.77.4.0590","volume":"77","author":"JM Markert","year":"1992","unstructured":"Markert JM, Coen DM, Malick A, Mineta T, Martuza RL. Expanded spectrum of viral therapy in the treatment of nervous system tumors. J Neurosurg. 1992;77(4):590\u20134.","journal-title":"J Neurosurg"},{"key":"4620_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.116553","volume":"408","author":"N Waldt","year":"2020","unstructured":"Waldt N, Scharnetzki D, Kesseler C, Kirches E, Stroscher N, Bohmer FD, et al. Loss of PTPRJ\/DEP-1 enhances NF2\/Merlin-dependent meningioma development. J Neurol Sci. 2020;408: 116553.","journal-title":"J Neurol Sci"},{"issue":"6","key":"4620_CR131","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1080\/01926230701584130","volume":"35","author":"JP Morrison","year":"2007","unstructured":"Morrison JP, Satoh H, Foley J, Horton JL, Dunnick JK, Kissling GE, et al. N-ethyl-N-nitrosourea (ENU)-induced meningiomatosis and meningioma in p16(INK4a)\/p19(ARF) tumor suppressor gene-deficient mice. Toxicol Pathol. 2007;35(6):780\u20137.","journal-title":"Toxicol Pathol"},{"issue":"4","key":"4620_CR132","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/bpa.12039","volume":"23","author":"M Peyre","year":"2013","unstructured":"Peyre M, Clermont-Taranchon E, Stemmer-Rachamimov A, Kalamarides M. Miniaturized handheld confocal microscopy identifies focal brain invasion in a mouse model of aggressive meningioma. Brain Pathol. 2013;23(4):371\u20137.","journal-title":"Brain Pathol"},{"issue":"36","key":"4620_CR133","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1038\/s41388-018-0328-7","volume":"37","author":"J Boetto","year":"2018","unstructured":"Boetto J, Apra C, Bielle F, Peyre M, Kalamarides M. Selective vulnerability of the primitive meningeal layer to prenatal Smo activation for skull base meningothelial meningioma formation. Oncogene. 2018;37(36):4955\u201363.","journal-title":"Oncogene"},{"issue":"13\u201314","key":"4620_CR134","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1101\/gad.349876.122","volume":"36","author":"F Szulzewsky","year":"2022","unstructured":"Szulzewsky F, Arora S, Arakaki AKS, Sievers P, Almiron Bonnin DA, Paddison PJ, et al. Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in mice. Genes Dev. 2022;36(13\u201314):857\u201370.","journal-title":"Genes Dev"},{"issue":"11","key":"4620_CR135","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1093\/neuonc\/noab075","volume":"23","author":"J Yeung","year":"2021","unstructured":"Yeung J, Yaghoobi V, Miyagishima D, Vesely MD, Zhang T, Badri T, et al. Targeting the CSF1\/CSF1R axis is a potential treatment strategy for malignant meningiomas. Neuro Oncol. 2021;23(11):1922\u201335.","journal-title":"Neuro Oncol"},{"issue":"6","key":"4620_CR136","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1227\/NEU.0b013e3181f9f310","volume":"67","author":"ZO Toktas","year":"2010","unstructured":"Toktas ZO, Akgun E, Ozkan A, Bozkurt SU, Bekiroglu N, Seker A, et al. Relationship of angiogenic potential with clinical features in cranial meningiomas: a corneal angiogenesis study. Neurosurgery. 2010;67(6):1724\u201332 (discussion 32).","journal-title":"Neurosurgery"},{"issue":"5","key":"4620_CR137","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.wneu.2013.06.021","volume":"80","author":"K Kilic","year":"2013","unstructured":"Kilic K, Avsar T, Akgun E, Ozkan A, Toktas ZO, Seker A, et al. Gamma knife radiosurgery inhibits angiogenesis of meningiomas: in vivo rat corneal assay. World Neurosurg. 2013;80(5):598\u2013604.","journal-title":"World Neurosurg"},{"issue":"5","key":"4620_CR138","first-page":"518","volume":"58","author":"SE Brooks","year":"1988","unstructured":"Brooks SE, Adachi M, Hoffman LM, Stein MR, Brooks J, Schneck L. Induction of lymphomas and fibrosarcomas in nude mice after implantation of simian virus 40-transformed human meningioma. Lab Invest. 1988;58(5):518\u201323.","journal-title":"Lab Invest"},{"issue":"7","key":"4620_CR139","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1158\/1541-7786.MCR-12-0116","volume":"10","author":"GS Baia","year":"2012","unstructured":"Baia GS, Caballero OL, Orr BA, Lal A, Ho JS, Cowdrey C, et al. Yes-associated protein 1 is activated and functions as an oncogene in meningiomas. Mol Cancer Res. 2012;10(7):904\u201313.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"4620_CR140","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11060-010-0469-1","volume":"104","author":"DY Hueng","year":"2011","unstructured":"Hueng DY, Sytwu HK, Huang SM, Chang C, Ma HI. Isolation and characterization of tumor stem-like cells from human meningiomas. J Neurooncol. 2011;104(1):45\u201353.","journal-title":"J Neurooncol"},{"issue":"2","key":"4620_CR141","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.yexmp.2010.12.003","volume":"90","author":"P Rath","year":"2011","unstructured":"Rath P, Miller DC, Litofsky NS, Anthony DC, Feng Q, Franklin C, et al. Isolation and characterization of a population of stem-like progenitor cells from an atypical meningioma. Exp Mol Pathol. 2011;90(2):179\u201388.","journal-title":"Exp Mol Pathol"},{"issue":"3","key":"4620_CR142","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0021-9975(05)80003-9","volume":"111","author":"J Yamate","year":"1994","unstructured":"Yamate J, Tajima M, Saitoh T, Shibuya K. Biological behaviour and morphological characteristics of a transplantable tumour (MM-KMY) derived from a malignant meningioma in an F344 rat. J Comp Pathol. 1994;111(3):243\u201357.","journal-title":"J Comp Pathol"},{"issue":"5","key":"4620_CR143","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s004010050640","volume":"93","author":"K Tsujino","year":"1997","unstructured":"Tsujino K, Yamate J, Tsukamoto Y, Kumagai D, Kannan Y, Jippo T, et al. Establishment and characterization of cell lines derived from a transplantable rat malignant meningioma: morphological heterogeneity and production of nerve growth factor. Acta Neuropathol. 1997;93(5):461\u201370.","journal-title":"Acta Neuropathol"},{"issue":"8","key":"4620_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2021.129929","volume":"1865","author":"QE Yang","year":"2021","unstructured":"Yang QE. Human cancer xenografts in immunocompromised mice provide an advanced genuine tumor model for research and drug development: a revisit of murine models for human cancers. Biochim Biophys Acta Gen Subj. 2021;1865(8): 129929.","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"5","key":"4620_CR145","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3171\/jns.1995.82.5.0864","volume":"82","author":"JC Tsai","year":"1995","unstructured":"Tsai JC, Goldman CK, Gillespie GY. Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg. 1995;82(5):864\u201373.","journal-title":"J Neurosurg"},{"issue":"2","key":"4620_CR146","first-page":"111","volume":"98","author":"JC Tsai","year":"1999","unstructured":"Tsai JC, Hsiao YY, Teng LJ, Shun CT, Chen CT, Goldman CK, et al. Regulation of vascular endothelial growth factor secretion in human meningioma cells. J Formos Med Assoc. 1999;98(2):111\u20137.","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"4620_CR147","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11060-005-9076-y","volume":"78","author":"GS Baia","year":"2006","unstructured":"Baia GS, Slocum AL, Hyer JD, Misra A, Sehati N, VandenBerg SR, et al. A genetic strategy to overcome the senescence of primary meningioma cell cultures. J Neurooncol. 2006;78(2):113\u201321.","journal-title":"J Neurooncol"},{"key":"4620_CR148","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab155","author":"S Yamazaki","year":"2021","unstructured":"Yamazaki S, Ohka F, Hirano M, Shiraki Y, Motomura K, Tanahashi K, et al. Newly established patient-derived organoid model of intracranial meningioma. Neuro Oncol. 2021. https:\/\/doi.org\/10.1093\/neuonc\/noab155.","journal-title":"Neuro Oncol"},{"issue":"5","key":"4620_CR149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178322","volume":"12","author":"Y Mei","year":"2017","unstructured":"Mei Y, Bi WL, Greenwald NF, Agar NY, Beroukhim R, Dunn GP, et al. Genomic profile of human meningioma cell lines. PLoS ONE. 2017;12(5): e0178322.","journal-title":"PLoS ONE"},{"issue":"4","key":"4620_CR150","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00401-003-0736-8","volume":"106","author":"K Akat","year":"2003","unstructured":"Akat K, Mennel HD, Kremer P, Gassler N, Bleck CK, Kartenbeck J. Molecular characterization of desmosomes in meningiomas and arachnoidal tissue. Acta Neuropathol. 2003;106(4):337\u201347.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"4620_CR151","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1006\/meth.2001.1159","volume":"24","author":"D Metzger","year":"2001","unstructured":"Metzger D, Chambon P. Site- and time-specific gene targeting in the mouse. Methods. 2001;24(1):71\u201380.","journal-title":"Methods"},{"issue":"6","key":"4620_CR152","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/nprot.2012.060","volume":"7","author":"A von Werder","year":"2012","unstructured":"von Werder A, Seidler B, Schmid RM, Schneider G, Saur D. Production of avian retroviruses and tissue-specific somatic retroviral gene transfer in vivo using the RCAS\/TVA system. Nat Protoc. 2012;7(6):1167\u201383.","journal-title":"Nat Protoc"},{"issue":"10","key":"4620_CR153","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1128\/jvi.61.10.3004-3012.1987","volume":"61","author":"SH Hughes","year":"1987","unstructured":"Hughes SH, Greenhouse JJ, Petropoulos CJ, Sutrave P. Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J Virol. 1987;61(10):3004\u201312.","journal-title":"J Virol"},{"issue":"10","key":"4620_CR154","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/jnen\/60.10.994","volume":"60","author":"A Perry","year":"2001","unstructured":"Perry A, Giannini C, Raghavan R, Scheithauer BW, Banerjee R, Margraf L, et al. Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases. J Neuropathol Exp Neurol. 2001;60(10):994\u20131003.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"4620_CR155","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10014-016-0271-7","volume":"33","author":"S Yuzawa","year":"2016","unstructured":"Yuzawa S, Nishihara H, Tanaka S. Genetic landscape of meningioma. Brain Tumor Pathol. 2016;33(4):237\u201347.","journal-title":"Brain Tumor Pathol"},{"issue":"3","key":"4620_CR156","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11060-010-0339-x","volume":"99","author":"S Goutagny","year":"2010","unstructured":"Goutagny S, Kalamarides M. Meningiomas and neurofibromatosis. J Neurooncol. 2010;99(3):341\u20137.","journal-title":"J Neurooncol"},{"key":"4620_CR157","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-017-0014-7","author":"WL Bi","year":"2017","unstructured":"Bi WL, Greenwald NF, Abedalthagafi M, Wala J, Gibson WJ, Agarwalla PK, et al. Genomic landscape of high-grade meningiomas. NPJ Genom Med. 2017. https:\/\/doi.org\/10.1038\/s41525-017-0014-7.","journal-title":"NPJ Genom Med"},{"key":"4620_CR158","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ceb.2017.11.005","volume":"51","author":"SS Mello","year":"2018","unstructured":"Mello SS, Attardi LD. Deciphering p53 signaling in tumor suppression. Curr Opin Cell Biol. 2018;51:65\u201372.","journal-title":"Curr Opin Cell Biol"},{"issue":"4","key":"4620_CR159","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3390\/cancers13040903","volume":"13","author":"V Barresi","year":"2021","unstructured":"Barresi V, Simbolo M, Fioravanzo A, Piredda ML, Caffo M, Ghimenton C, et al. Molecular profiling of 22 primary atypical meningiomas shows the prognostic significance of 18q heterozygous loss and CDKN2A\/B homozygous deletion on recurrence-free survival. Cancers (Basel). 2021;13(4):903.","journal-title":"Cancers (Basel)."},{"issue":"3","key":"4620_CR160","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-020-02188-w","volume":"140","author":"P Sievers","year":"2020","unstructured":"Sievers P, Hielscher T, Schrimpf D, Stichel D, Reuss DE, Berghoff AS, et al. CDKN2A\/B homozygous deletion is associated with early recurrence in meningiomas. Acta Neuropathol. 2020;140(3):409\u201313.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"4620_CR161","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/S0006-291X(03)00080-9","volume":"301","author":"M Matsuoka","year":"2003","unstructured":"Matsuoka M, Kurita M, Sudo H, Mizumoto K, Nishimoto I, Ogata E. Multiple domains of the mouse p19ARF tumor suppressor are involved in p53-independent apoptosis. Biochem Biophys Res Commun. 2003;301(4):1000\u201310.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"4620_CR162","first-page":"F115","volume":"1378","author":"M Ruas","year":"1998","unstructured":"Ruas M, Peters G. The p16INK4a\/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta. 1998;1378(2):F115\u201377.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"4620_CR163","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3","volume":"187","author":"C Prives","year":"1999","unstructured":"Prives C, Hall PA. The p53 pathway. J Pathol. 1999;187(1):112\u201326.","journal-title":"J Pathol"},{"issue":"1","key":"4620_CR164","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s41467-021-22327-5","volume":"12","author":"Y Xia","year":"2021","unstructured":"Xia Y, Liu Y, Yang C, Simeone DM, Sun TT, DeGraff DJ, et al. Dominant role of CDKN2B\/p15INK4B of 9p21.3 tumor suppressor hub in inhibition of cell-cycle and glycolysis. Nat Commun. 2021;12(1):2047.","journal-title":"Nat Commun"},{"issue":"8","key":"4620_CR165","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231\u201351.","journal-title":"Neuro Oncol"},{"issue":"1","key":"4620_CR166","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/ijc.2910460106","volume":"46","author":"M Maxwell","year":"1990","unstructured":"Maxwell M, Galanopoulos T, Hedley-Whyte ET, Black PM, Antoniades HN. Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products. Int J Cancer. 1990;46(1):16\u201321.","journal-title":"Int J Cancer"},{"issue":"3","key":"4620_CR167","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3171\/jns.1994.81.3.0388","volume":"81","author":"PM Black","year":"1994","unstructured":"Black PM, Carroll R, Glowacka D, Riley K, Dashner K. Platelet-derived growth factor expression and stimulation in human meningiomas. J Neurosurg. 1994;81(3):388\u201393.","journal-title":"J Neurosurg"},{"issue":"3","key":"4620_CR168","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ng.2526","volume":"45","author":"PK Brastianos","year":"2013","unstructured":"Brastianos PK, Horowitz PM, Santagata S, Jones RT, McKenna A, Getz G, et al. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet. 2013;45(3):285\u20139.","journal-title":"Nat Genet"},{"issue":"1","key":"4620_CR169","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00401-019-02095-9","volume":"139","author":"P Sievers","year":"2020","unstructured":"Sievers P, Chiang J, Schrimpf D, Stichel D, Paramasivam N, Sill M, et al. YAP1-fusions in pediatric NF2-wildtype meningioma. Acta Neuropathol. 2020;139(1):215\u20138.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"4620_CR170","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s12079-021-00643-1","volume":"16","author":"A Passaniti","year":"2022","unstructured":"Passaniti A, Kleinman HK, Martin GR. Matrigel: history\/background, uses, and future applications. J Cell Commun Signal. 2022;16(4):621\u20136.","journal-title":"J Cell Commun Signal"},{"issue":"17","key":"4620_CR171","doi-asserted-by":"publisher","first-page":"6698","DOI":"10.1073\/pnas.87.17.6698","volume":"87","author":"R Fridman","year":"1990","unstructured":"Fridman R, Giaccone G, Kanemoto T, Martin GR, Gazdar AF, Mulshine JL. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc Natl Acad Sci USA. 1990;87(17):6698\u2013702.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"4620_CR172","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/ijc.2910510513","volume":"51","author":"R Fridman","year":"1992","unstructured":"Fridman R, Sweeney TM, Zain M, Martin GR, Kleinman HK. Malignant transformation of NIH-3T3 cells after subcutaneous co-injection with a reconstituted basement membrane (matrigel). Int J Cancer. 1992;51(5):740\u20134.","journal-title":"Int J Cancer"},{"issue":"1","key":"4620_CR173","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13046-016-0462-4","volume":"35","author":"L Pompili","year":"2016","unstructured":"Pompili L, Porru M, Caruso C, Biroccio A, Leonetti C. Patient-derived xenografts: a relevant preclinical model for drug development. J Exp Clin Cancer Res. 2016;35(1):189.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4620_CR174","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2015.08.068","volume":"163","author":"CP Day","year":"2015","unstructured":"Day CP, Merlino G, Van Dyke T. Preclinical mouse cancer models: a maze of opportunities and challenges. Cell. 2015;163(1):39\u201353.","journal-title":"Cell"},{"issue":"2","key":"4620_CR175","doi-asserted-by":"publisher","first-page":"137","DOI":"10.15252\/emmm.201606857","volume":"9","author":"K Kersten","year":"2017","unstructured":"Kersten K, de Visser KE, van Miltenburg MH, Jonkers J. Genetically engineered mouse models in oncology research and cancer medicine. EMBO Mol Med. 2017;9(2):137\u201353.","journal-title":"EMBO Mol Med"},{"issue":"4","key":"4620_CR176","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrc777","volume":"2","author":"J Jonkers","year":"2002","unstructured":"Jonkers J, Berns A. Conditional mouse models of sporadic cancer. Nat Rev Cancer. 2002;2(4):251\u201365.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"4620_CR177","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1101\/pdb.top069831","volume":"2014","author":"LG Ahronian","year":"2014","unstructured":"Ahronian LG, Lewis BC. Using the RCAS-TVA system to model human cancer in mice. Cold Spring Harb Protoc. 2014;2014(11):1128\u201335.","journal-title":"Cold Spring Harb Protoc"},{"issue":"11","key":"4620_CR178","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1021\/acs.accounts.9b00391","volume":"52","author":"SJ Williams","year":"2019","unstructured":"Williams SJ, Prescher JA. Building biological flashlights: orthogonal luciferases and luciferins for in vivo imaging. Acc Chem Res. 2019;52(11):3039\u201350.","journal-title":"Acc Chem Res"},{"key":"4620_CR179","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-3-319-55825-7_2","volume-title":"Patient-derived xenograft models of human cancer","author":"GP Risbridger","year":"2017","unstructured":"Risbridger GP, Lawrence MG. Towards best practice in establishing patient-derived xenografts. In: Wang Y, Lin D, Gout PW, editors. Patient-derived xenograft models of human cancer. Cham: Springer International Publishing; 2017. p. 11\u201328."},{"issue":"20","key":"4620_CR180","first-page":"4670","volume":"55","author":"SA Hahn","year":"1995","unstructured":"Hahn SA, Seymour AB, Hoque AT, Schutte M, da Costa LT, Redston MS, et al. Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res. 1995;55(20):4670\u20135.","journal-title":"Cancer Res"},{"issue":"3","key":"4620_CR181","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2144\/000113363","volume":"48","author":"MT Lin","year":"2010","unstructured":"Lin MT, Tseng LH, Kamiyama H, Kamiyama M, Lim P, Hidalgo M, et al. Quantifying the relative amount of mouse and human DNA in cancer xenografts using species-specific variation in gene length. Biotechniques. 2010;48(3):211\u20138.","journal-title":"Biotechniques"},{"issue":"3","key":"4620_CR182","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3171\/2011.10.JNS11852","volume":"116","author":"K Iwami","year":"2012","unstructured":"Iwami K, Momota H, Natsume A, Kinjo S, Nagatani T, Wakabayashi T. A novel method of intracranial injection via the postglenoid foramen for brain tumor mouse models. J Neurosurg. 2012;116(3):630\u20135.","journal-title":"J Neurosurg"},{"issue":"9","key":"4620_CR183","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043404","volume":"7","author":"G ter Riet","year":"2012","unstructured":"ter Riet G, Korevaar DA, Leenaars M, Sterk PJ, Van Noorden CJ, Bouter LM, et al. Publication bias in laboratory animal research: a survey on magnitude, drivers, consequences and potential solutions. PLoS ONE. 2012;7(9): e43404.","journal-title":"PLoS ONE"},{"issue":"3","key":"4620_CR184","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/PAS.0000000000001597","volume":"45","author":"KM Schieffer","year":"2021","unstructured":"Schieffer KM, Agarwal V, LaHaye S, Miller KE, Koboldt DC, Lichtenberg T, et al. YAP1-FAM118B fusion defines a rare subset of childhood and young adulthood meningiomas. Am J Surg Pathol. 2021;45(3):329\u201340.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"4620_CR185","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0976-500X.119726","volume":"4","author":"J Charan","year":"2013","unstructured":"Charan J, Kantharia ND. How to calculate sample size in animal studies? J Pharmacol Pharmacother. 2013;4(4):303\u20136.","journal-title":"J Pharmacol Pharmacother"},{"issue":"2","key":"4620_CR186","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/cancers15020483","volume":"15","author":"A Shahbandi","year":"2023","unstructured":"Shahbandi A, Shah DS, Hadley CC, Patel AJ. The role of pharmacotherapy in treatment of meningioma: a systematic review. Cancers (Basel). 2023;15(2):483.","journal-title":"Cancers (Basel)."},{"issue":"5","key":"4620_CR187","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1007\/s10143-022-01849-6","volume":"45","author":"LR Jensen","year":"2022","unstructured":"Jensen LR, Maier AD, Lomstein A, Graillon T, Hrachova M, Bota D, et al. Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient data. Neurosurg Rev. 2022;45(5):3067\u201381.","journal-title":"Neurosurg Rev"},{"issue":"6","key":"4620_CR188","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/neuonc\/not330","volume":"16","author":"T Kaley","year":"2014","unstructured":"Kaley T, Barani I, Chamberlain M, McDermott M, Panageas K, Raizer J, et al. Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review. Neuro Oncol. 2014;16(6):829\u201340.","journal-title":"Neuro Oncol"},{"issue":"1","key":"4620_CR189","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1161\/CIRCRESAHA.114.303819","volume":"116","author":"CG Begley","year":"2015","unstructured":"Begley CG, Ioannidis JP. Reproducibility in science: improving the standard for basic and preclinical research. Circ Res. 2015;116(1):116\u201326.","journal-title":"Circ Res"},{"issue":"7391","key":"4620_CR190","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/483531a","volume":"483","author":"CG Begley","year":"2012","unstructured":"Begley CG, Ellis LM. Drug development: raise standards for preclinical cancer research. Nature. 2012;483(7391):531\u20133.","journal-title":"Nature"},{"issue":"9","key":"4620_CR191","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1289\/ehp.1206389","volume":"121","author":"D Krauth","year":"2013","unstructured":"Krauth D, Woodruff TJ, Bero L. Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review. Environ Health Perspect. 2013;121(9):985\u201392.","journal-title":"Environ Health Perspect"},{"issue":"21","key":"4620_CR192","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1158\/0008-5472.CAN-16-1260","volume":"76","author":"JJ Morton","year":"2016","unstructured":"Morton JJ, Bird G, Refaeli Y, Jimeno A. Humanized mouse xenograft models: narrowing the tumor-microenvironment gap. Cancer Res. 2016;76(21):6153\u20138.","journal-title":"Cancer Res"},{"issue":"10","key":"4620_CR193","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","volume":"174","author":"LD Shultz","year":"2005","unstructured":"Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, et al. Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol. 2005;174(10):6477\u201389.","journal-title":"J Immunol"},{"issue":"3","key":"4620_CR194","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2967\/jnumed.114.149120","volume":"56","author":"W Rachinger","year":"2015","unstructured":"Rachinger W, Stoecklein VM, Terpolilli NA, Haug AR, Ertl L, Poschl J, et al. Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue. J Nucl Med. 2015;56(3):347\u201353.","journal-title":"J Nucl Med"},{"issue":"9","key":"4620_CR195","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00259-012-2155-3","volume":"39","author":"A Afshar-Oromieh","year":"2012","unstructured":"Afshar-Oromieh A, Giesel FL, Linhart HG, Haberkorn U, Haufe S, Combs SE, et al. Detection of cranial meningiomas: comparison of (6)(8)Ga-DOTATOC PET\/CT and contrast-enhanced MRI. Eur J Nucl Med Mol Imaging. 2012;39(9):1409\u201315.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"4620_CR196","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13014-021-01875-6","volume":"16","author":"ES Kowalski","year":"2021","unstructured":"Kowalski ES, Khairnar R, Gryaznov AA, Kesari V, Koroulakis A, Raghavan P, et al. (68)Ga-DOTATATE PET-CT as a tool for radiation planning and evaluating treatment responses in the clinical management of meningiomas. Radiat Oncol. 2021;16(1):151.","journal-title":"Radiat Oncol"},{"issue":"1","key":"4620_CR197","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41588-020-00750-6","volume":"53","author":"XY Woo","year":"2021","unstructured":"Woo XY, Giordano J, Srivastava A, Zhao ZM, Lloyd MW, de Bruijn R, et al. Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts. Nat Genet. 2021;53(1):86\u201399.","journal-title":"Nat Genet"},{"issue":"10","key":"4620_CR198","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1101\/gad.11.10.1253","volume":"11","author":"AI McClatchey","year":"1997","unstructured":"McClatchey AI, Saotome I, Ramesh V, Gusella JF, Jacks T. The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation. Genes Dev. 1997;11(10):1253\u201365.","journal-title":"Genes Dev"},{"issue":"6121","key":"4620_CR199","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. Multiplex genome engineering using CRISPR\/Cas systems. Science. 2013;339(6121):819\u201323.","journal-title":"Science"},{"key":"4620_CR200","doi-asserted-by":"publisher","first-page":"10770","DOI":"10.1038\/ncomms10770","volume":"7","author":"R Maresch","year":"2016","unstructured":"Maresch R, Mueller S, Veltkamp C, Ollinger R, Friedrich M, Heid I, et al. Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR\/Cas9 delivery in mice. Nat Commun. 2016;7:10770.","journal-title":"Nat Commun"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04620-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04620-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04620-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T06:05:14Z","timestamp":1698473114000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04620-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,28]]},"references-count":200,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4620"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04620-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,28]]},"assertion":[{"value":"25 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"764"}}